Company Filing History:
Years Active: 2009-2022
Title: Noelle Williams: Innovator in Cardiac Treatment
Introduction
Noelle Williams is a prominent inventor based in Dallas, TX, who has made significant contributions to the field of cardiac treatment. With two patents to her name, she has focused her research on innovative methods to address coronary disorders and improve heart health.
Latest Patents
Her latest patents include "Inhibitors of short-chain dehydrogenase activity for treating coronary disorders," which outlines a method for treating, preventing, minimizing, and reversing congestive heart failure and related conditions. This method involves administering a therapeutically effective amount of a 15-PGDH inhibitor to patients in need. Another notable patent is for a "Diazonamide A analog," which describes a specific diazonamide A analog and its salts and conjugates that are effective in treating proliferative diseases.
Career Highlights
Noelle has worked with esteemed institutions such as the University of Texas System and Case Western Reserve University. Her work has been instrumental in advancing research in cardiac health and treatment methodologies.
Collaborations
Some of her notable coworkers include Sanford D. Markowitz and Won Jin Ho, who have collaborated with her on various research projects.
Conclusion
Noelle Williams stands out as an innovative inventor dedicated to improving cardiac health through her groundbreaking patents and research efforts. Her contributions continue to influence the medical field and offer hope for better treatment options for patients with heart conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.